• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 29, 2025
Finance

Autoimmune play Hillstar takes wing with $67M series A: Finance Report

Plus: Novo Holdings, Jeito lead week’s largest A round for VIB company Augustine — and more
Read More
BioCentury | Dec 1, 2023
Discovery & Translation

CorrectSequence’s hemoglobin base editor; plus Denali’s LXR agonist and more

BioCentury’s roundup of translational innovations
Read More
BioCentury | Aug 23, 2023
Distillery Therapeutics

Engineered oncolytic virus expressing APOA1 for glioblastoma

Read More
BioCentury | Feb 2, 2018
Translation in Brief

Untangling MS

How screening cell by cell could help target MS disability by disability
Read More
BioCentury | Feb 1, 2018
Distillery Therapeutics

Autoimmune disease

Read More
BioCentury | May 31, 2017
Distillery Techniques

Disease models

Read More
BioCentury | Jul 27, 2015
Clinical News

MDCO-216: Phase I data

Read More
BioCentury | Mar 27, 2015
Financial News

Cerenis raises EUR 53.4M in Euronext IPO

Read More
BioCentury | Sep 15, 2014
Clinical News

Cerenis HDL regulatory update

Read More
BioCentury | Oct 10, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Read More
Items per page:
1 - 10 of 21